DSM-Firmenich AG (DSFIR.AS): analysis and signal as of September 8, 2026

Published on September 3, 2026 at 18:38 · Updated on September 8, 2026 at 12:56 · by Aurélien Ambert, QDNA

Exchange : Euronext Amsterdam · Sector : Consumer Non-Durables (Flavors, Ingredients)

In short

The signal is weak with a score of -2,0. The price is in line with the average consensus target, which removes the margin of safety.

Current signal: weak (vote 3/3)
Deterministic score: -2.0 → signal expected by the scale : no signal (September 10, 2026)
Layers: fundamentals : positive, price : positive, risks : positive

Triggered rules

Rule	Weight
penalizes an asset whose net debt/EBITDA exceeds the threshold, and the use of leverage (margin/lombard)	-2.5
moderately favors a positive 12-1 month momentum (tailwind), BUT guardrail: costly rotation, long-term reversal, momentum crashes, a conviction signal, not a rotation trigger	+0.5

Thesis

DSM-Firmenich AG operates in specialty chemicals. Adjusted EBITDA margins are solid. Guidance has been raised to the high end of the range. Buybacks of 90 M EUR and the dividend of 2,50 EUR support the valuation. The price is in line with the average consensus target. The margin of safety no longer exists. The sector is not favored by the macro regime. Cboe complacency limits protection against a shock.

Bull case

Core EPS for the first half of 2026 increases by 14 % to 1,84 EUR. LFL sales rise by 5 %. LFL EBITDA grows by 7 %. Guidance has been raised to the high end of the range. Buybacks of 90 M EUR are completed. Citi targets 99 EUR. The macro regime is in expansion with a bullish weighting of 0,58.

Bear case

The price of 93,06 EUR is in line with the average target of 93,67 EUR. The consensus upside margin is zero. The stock trades 32 % above the 200-day moving average. The extension approaches the cycle high. Short interest reaches 3,5 %. The deterministic score is -0.50. The sector is not favored by the macro regime. Cboe complacency amplifies the risk of an uncovered correction.

Scenarios

The bullish scenario relies on the guidance upgrade and margin strength. The bearish scenario stems from the price being in line with the average target. The risk of an uncovered correction remains. Cboe complacency limits protection.

Risks

The average correlation is 0,06. Downside asymmetry reaches 0,51. The variance gain is 5,7 %. This gain is justified at the average size. It is not justified beyond that. Cboe complacency amplifies the risk of an uncovered correction.

Upcoming catalysts

Date	Description
October 29, 2026	Publication of T3 2026 revenue

Signal history (last 12 months)

Date	Signal	New fact
September 8, 2026	weak (3/3)	The verdict of 02/09/2026 is maintained. The dated new fact is the release of 07/09/2026. It raises 2026 guidance to the high end of the range with revenue of +2 to +4 %. Short interest is 3,5 % published on 06/09/2026. The price of 93,06 EUR remains in line with the average target of 93,67 EUR. The new fact is positive but insufficient to change the signal.
September 2, 2026	weak (2/2)	The current deterministic score of -2,00 from 02/09/2026 is maintained. The high-leverage rule is at -2,5. The debt level is not verified directly. It is marked as possibly expired by the fundamentals layer. This internal recalculation is neither a result, nor a guidance, nor a price, nor a dated regulation. No layer has produced a verified new fact since the verdict of 31/08/2026. The weak verdict is maintained. The fundamentals layer remains nearly silent.
August 31, 2026	weak (single draw, outside the three-draw protocol)	unchanged

Frequently asked questions

Why is the signal weak?

The price of 93,06 EUR is in line with the average consensus target of 93,67 EUR. The margin of safety no longer exists. The sector is not on the list of favorites for the macro regime. Cboe complacency limits protection against a shock. The score is -2.0.

What are the recent positive facts?

Guidance was raised to the high end of the range on 07/09/2026. Buybacks of 90 M EUR are completed. Core EPS for the first half of 2026 increases by 14 %. LFL sales rise by 5 %. LFL EBITDA grows by 7 %. Citi targets 99 EUR.

What is the main risk?

The price trades 32 % above the 200-day moving average. The extension approaches the cycle high. Short interest reaches 3,5 %. The deterministic score is -0.50. Cboe complacency amplifies the risk of an uncovered correction. The sector is not favored by the macro regime.

What is the margin situation?

Adjusted EBITDA margins are solid. The rate is 19,5 %. The 2026 target is 20 %. The 2027 target is 21 %. These levels support the valuation. The dividend of 2,50 EUR offers a payout of 30,3 %.

Sources

No official filing is attached to this stock in the database to date. The figures quoted above come from an automated arbitration: they have not been re-checked one by one.

Automated AI analysis: limitations and transparency

This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
Tool and analysis: QDNA, Aurélien Ambert.
Analysis (arbitration) completed on September 8, 2026; this page was completed on September 8, 2026 at 12:56 (UTC).
Interests: no position in the stock analysed (DSFIR.AS) is recorded in the data consulted on September 12, 2026 (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
Methodology: analysis chain, score formula and scale described on the public methodology page.
Analysis horizon: 2035.